United States · Series B startup

Who invested in Aristea Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$78Mraised across 2 rounds since 2018, from 2 sources

$15MSeries A$63MSeries B
Latest round
Series B, $63MJul 2021
Step-upi
4.2×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021
$15MSeries A$63MSeries B
First round
Series A, $15M
Dec 2018
Biggest round
$63M
Series B · Jul 2021
Between rounds
2.5 years
from the last two

The rounds

  1. Jul 2021
    Series B$63M2 new

    Source recordedSEC filing: $63M sold, first sale Oct 2020

  2. Dec 2018
    Series A$15M1 new

    Reported by FinSMEs

Founders and team

From the SEC filings it signed: 1 on the team.

  • James MackayExecutive Officer, Directori

On the board, as filediCiara KennedyKenneth HarrisonLoretta TseTiba Aynechi

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

FidelityVC firm1round
Novo HoldingsVC firm1round
Novo Holdings A/SGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aristea Therapeutics

Who invested in Aristea Therapeutics?

Aristea Therapeutics's investors include Fidelity, Novo Holdings and Novo Holdings A/S.

How much has Aristea Therapeutics raised?

Aristea Therapeutics has raised $78M across 2 rounds since 2018.

When did Aristea Therapeutics last raise?

Aristea Therapeutics's most recent round was a Series B of $63M in Jul 2021.

What was Aristea Therapeutics's biggest round?

Its most recent round, $63M in Jul 2021, is also its largest on record.

Who backed Aristea Therapeutics first?

Aristea Therapeutics's first round on record, in Dec 2018, was backed by Novo Holdings A/S.

What stage is Aristea Therapeutics at?

Aristea Therapeutics's latest named round is a Series B, in Jul 2021.

Where is Aristea Therapeutics based?

Aristea Therapeutics is based in the United States.

Companies like Aristea Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.